- Home
- PRLD vs PNF Comparison
PRLD vs PNF Comparison
Compare PRLD & PNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- PNF
- Stock Information
- Founded
- PRLD 2016
- PNF 2001
- Country
- PRLD United States
- PNF United States
- Employees
- PRLD N/A
- PNF N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- PNF Finance Companies
- Sector
- PRLD Health Care
- PNF Finance
- Exchange
- PRLD Nasdaq
- PNF Nasdaq
- Market Cap
- PRLD 73.7M
- PNF 59.6M
- IPO Year
- PRLD 2020
- PNF N/A
- Fundamental
- Price
- PRLD $0.82
- PNF $7.49
- Analyst Decision
- PRLD Strong Buy
- PNF
- Analyst Count
- PRLD 2
- PNF 0
- Target Price
- PRLD $4.50
- PNF N/A
- AVG Volume (30 Days)
- PRLD 201.7K
- PNF 29.1K
- Earning Date
- PRLD 03-10-2025
- PNF 01-01-0001
- Dividend Yield
- PRLD N/A
- PNF 5.17%
- EPS Growth
- PRLD N/A
- PNF N/A
- EPS
- PRLD N/A
- PNF N/A
- Revenue
- PRLD $7,000,000.00
- PNF N/A
- Revenue This Year
- PRLD N/A
- PNF N/A
- Revenue Next Year
- PRLD N/A
- PNF N/A
- P/E Ratio
- PRLD N/A
- PNF N/A
- Revenue Growth
- PRLD N/A
- PNF N/A
- 52 Week Low
- PRLD $0.63
- PNF $6.37
- 52 Week High
- PRLD $6.80
- PNF $9.06
- Technical
- Relative Strength Index (RSI)
- PRLD 56.29
- PNF 39.49
- Support Level
- PRLD $0.71
- PNF $7.40
- Resistance Level
- PRLD $0.76
- PNF $7.76
- Average True Range (ATR)
- PRLD 0.07
- PNF 0.09
- MACD
- PRLD 0.02
- PNF -0.01
- Stochastic Oscillator
- PRLD 87.50
- PNF 25.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About PNF PIMCO New York Municipal Income Fund
PIMCO New York Municipal Income Fund is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund's portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.